New Covenant Trust Company »

Denali Therapeutics shares owned by New Covenant Trust Company

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by New Covenant Trust Company from 13F filings

Historical chart of New Covenant Trust Company investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by New Covenant Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by New Covenant Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $16k 784 20.52

More positions owned by New Covenant Trust Company

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard World Esg Us Stk Etf (ESGV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard World Esg Intl Stk Etf (VSGX)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Usa Esg Slc (SUSA)
Amazon (AMZN)
Fidelity Covington Trust Fundamental Larg (FFLC)
Vanguard Index Fds Sm Cp Val Etf (VBR)

View all positions for New Covenant Trust Company

Top funds holding Denali Therapeutics

Baillie Gifford & Co
BlackRock
Vanguard Group
Wellington Management Company
Capital Research Global Investors
Temasek Holdings
Crestline Management
State Street Corporation
Baker Bros. Advisors
Geode Capital Management
Marshall Wace
T. Rowe Price Associates
Alliancebernstein
Credit Suisse
Bank of New York Mellon

View all funds holding Denali Therapeutics